AzTrials
AzTrials

Heart FailurePhase 4SEDICNCT00878202

Therapeutic Education by Telemedicine in Chronic Heart Failure

A Phase 4 study testing SCAD information system in people with Heart Failure, run by University Hospital, Caen at 6 sites in France.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The purpose of the SEDIC study is to test a home based heart failure patient clinical follow-up and therapeutic education using telemedicine. This educational follow-up is based on an interactive information system (SCAD) including a touch screen personal computer for heart failure patient at home. Read more about this study

Who is it for?
Ages 65 to 95 years
Conditions the study is for
Heart Failure
What is being tested?
SCAD information system
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
6 sitesFrance
Study dates
Mar 2009to Jun 2012
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 to 95 years
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Patients > 65 years old hospitalized for acute heart failure
  • Left ventricle systolic Dysfunction with ejection fraction < 45 %, documented in the previous 6 months
  • And at least one of the following criteria:
  • BNP before discharge from hospital > 350 pg/ml / EF < 35 % / Hospitalization for acute heart failure informed in the previous 6 months

Who cannot join

  • NYHA 4 at hospital discharge
  • Planned cardiac surgery or coronary revascularization
  • Hospitalization for ST-elevation acute coronary syndrome
  • Depressive syndrome with score > 20 at geriatric depression scale
  • Therapeutic education impossible
  • Technical problems with the device
Show all 9Show fewer
  • Limited autonomy for device use
  • Patient not living in Basse-Normandie
  • Ongoing participation in another clinical trial

Trial locations and contacts

6 sites in 1 country.

6 sites in 1 country

France6 sites
  • Alençon-Mamers Hospital

    Alençon, 61000

  • Caen University Hospital

    Caen

  • Cherbourg Hospital

    Cherbourg

  • Flers Hospital

    Flers

  • Lisieux Hospital

    Lisieux, 14100

  • Saint-Lo Hospital

    Saint-Lô, 50009

Other trials in France

About this study

Official title: Impact of Clinical Follow-up and Therapeutic Education by Telemedicine in Chronic Heart Failure: a Randomized Multicenter Study.

The purpose of the SEDIC study is to test a home based heart failure patient clinical follow-up and therapeutic education using telemedicine. This educational follow-up is based on an interactive information system (SCAD) including a touch screen personal computer for heart failure patient at home. An interactive algorithm has been developed to allow a self management teaching to the patient.Furthermore, a specialized nurse provide a clinical data follow-up.

Conditions
Heart Failure
Being tested
SCAD information system
Medical subject headings
Heart Failure

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SCAD information systemDevice

    Clinical follow-up and continuation of therapeutic education by telemedicine during 3 months

Study groups in NCT00878202
Study groupRoleWhat they receive
ControlNo interventionOptimal medical treatment of Heart failure and therapeutic education
TelemedicineExperimentalOptimal medical treatment of heart failure disease and therapeutic education
Receives: Device: SCAD information system

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of hospitalization days for heart failure

    Measured: 12 months

Secondary outcomes (10)
  1. Cardiovascular mortality

    Measured: 12 months

  2. Total mortality

    Measured: 12 months

  3. Rate of hospitalization for heart failure

    Measured: 12 months

  4. Median of time up to mortality or hospitalization for heart failure

    Measured: 12 months

  5. Number of medical consultation

    Measured: 12 months

  6. Pharmaco-economic analysis

    Measured: 12 months

  7. Disease knowledge questionnaire

    Measured: 12 months

  8. Quality of life questionnaire ( Minnesota)

    Measured: 12 months

  9. BNP

    Measured: 12 months

  10. Six minutes walk test

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Apr 2009 (estimated)
  2. Study startMar 2009
  3. Primary completionJun 2012
  4. Study completionJun 2012

Why it stopped: Insufficient recruitment

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00878202
Sponsor's protocol ID
B80909-60
Acronym
SEDIC
Status last verified
Feb 2013
First submitted
6 Apr 2009
Last updated
20 Feb 2013
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing SCAD information system in people with Heart Failure, run by University Hospital, Caen at 6 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 20 Feb 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 6 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study was stopped early (reason given: Insufficient recruitment). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of hospitalization days for heart failure (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Feb 2013; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in